Mainz Biomed NV MYNZ:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:53 AM EST
6.75quote price arrow down-0.05 (-0.74%)
Volume
2,670
52 week range
6.06 - 18.63
Loading...
  • Open6.80
  • Day High6.90
  • Day Low6.75
  • Prev Close6.80
  • 52 Week High18.63
  • 52 Week High Date02/17/22
  • 52 Week Low6.06
  • 52 Week Low Date09/23/22

Key Stats

  • Market Cap97.81M
  • Shares Out14.49M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-4.93

KEY STATS

  • Open6.80
  • Day High6.90
  • Day Low6.75
  • Prev Close6.80
  • 52 Week High18.63
  • 52 Week High Date02/17/22
  • 52 Week Low6.06
  • 52 Week Low Date09/23/22
  • Market Cap97.81M
  • Shares Out14.49M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-4.93

RATIOS/PROFITABILITY

  • EPS (TTM)-1.33
  • P/E (TTM)-5.07
  • Fwd P/E (NTM)-4.34
  • EBITDA (TTM)-22.014M
  • ROE (TTM)-225.01%
  • Revenue (TTM)400,000.00
  • Gross Margin (TTM)30.53%
  • Net Margin (TTM)-6,009.96%
  • Debt To Equity (MRQ)8.43%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Mainz Biomed NV

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in...
Guido Baechler
Chief Executive Officer, Director
Philipp Freese
Chief Operating Officer
William Caragol
Chief Financial Officer
Address
Sirius Gutenberg Park
Robert-Koch-Strasse 50
Mainz
55129
Germany